GlassScriptPhysician profile
Bea Paula Salvanera
NPI 1902493208
$8,623.55
in general payments reported to CMS, 2019-2025
24 companies · $2,283 in 2025
The $2,283 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,567 · 2022: $1,992 · 2023: $1,757 · 2024: $25.32 · 2025: $2,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,438 · Travel and Lodging: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,438.17 |
| Travel and Lodging | $627.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,862.01 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Nevro Corp. | $1,652.19 | 2021-2023 | Senza |
| Abbott Laboratories | $1,360.80 | 2021-2025 | Proclaim, Prodigy, Axium |
| Vertos Medical, INC. | $1,087.19 | 2021-2023 | Mild Device Kit |
| Nalu Medical, INC. | $1,073.21 | 2021-2023 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $258.25 | 2023-2025 | Qutenza |
| Inspire Medical Systems, INC. | $188.97 | 2024-2025 | Inspire |
| Abbvie INC. | $181.32 | 2021-2023 | |
| Curonix LLC | $150.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $135.24 | 2022 | |
| Collegium Pharmaceutical, INC. | $121.69 | 2021-2023 | Belbuca |
| Saluda Medical Americas, INC. | $105.58 | 2025 | Evoke |
| Biodelivery Sciences International, INC. | $84.74 | 2021 | |
| Foundation Fusion Solutions, LLC | $56.21 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $54.18 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $45.67 | 2021 | |
| Hikma Pharmaceuticals USA | $38.56 | 2022 | |
| Scilex Pharmaceuticals INC. | $35.09 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $33.74 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.23 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.54 | 2022 | |
| Zoll Respicardia, INC. | $19.68 | 2023 | Remede System |
| Horizon Therapeutics Plc | $15.38 | 2022 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bea Paula Salvanera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.